Announcements

Vasomedical Announces Biox’s MobiCare™ Wireless Patient Monitors Receives Marketing Approval in China

  March 17, 2014   By Vaso Corporation announcements , news

WESTBURY, N.Y., March 17, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, including EECP® Therapy systems, the gold standard of ECP therapy, today announced that its wholly owned subsidiary Biox Instruments Co. Ltd., based in Wuxi, China, has received approval...
Read More

FDA Reclassifies ECP Devices for Refractory Angina as Class II

  January 6, 2014   By Vaso Corporation announcements , news

WESTBURY... N.Y.... Jan. 6... 2014 /PRNewswire/ — Vasomedical... Inc. (“Vasomedical”) (OTCBB: VASO)... a diversified medical technology company specializing in the design... manufacture and sale of medical devices including EECP® (Enhanced External Counterpulsation) Therapy systems... the gold standard of ECP therapy... announced today that the U.S. Food and Drug Administration (FDA)... Department of Health and Human Services...
Read More

Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013

  November 14, 2013   By Vaso Corporation announcements , news

WESTBURY, N.Y., Nov. 14, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended September 30, 2013. “We are pleased to report that during the third quarter of 2013 the Company recorded significant growth in both the Equipment segment and the Sales Representation segment.  Total equipment sales...
Read More

Vasomedical Again Named on Deloitte’s Technology Fast 500 List

  November 13, 2013   By Vaso Corporation announcements , news

WESTBURY, N.Y., Nov. 13, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology, including EECP® Therapy systems, the gold standard of ECP therapy, today announced it has been named to the Deloitte’s Technology Fast 500™ for the second consecutive...
Read More

EECP Therapy Receives Class lla Recommendation in European Society of Cardiology Guidelines for the Management of Stable Coronary Artery Disease

  September 9, 2013   By Vaso Corporation announcements , news

WESTBURY, N.Y., Sept. 9, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® (Enhanced External Counterpulsation) Therapy systems, the gold standard of ECP therapy, announced today that its EECP Therapy has been given a lla Class of Recommendation...
Read More